Bristol-Myers Squibb Company
TREATMENT OF LUNG CANCER USING AN ANTI-FUCOSYL-GM1 ANTIBODY
Last updated:
Abstract:
This disclosure provides a method for treating a subject afflicted with a lung cancer, which method comprises administering to the subject a therapeutically effective amount of an antibody or an antigen-binding portion thereof that specifically binds to Fucosyl-GM1.
Status:
Application
Type:
Utility
Filling date:
6 Sep 2019
Issue date:
26 Dec 2019